|
Volumn 11, Issue 1, 2003, Pages 39-53
|
Summary of guideline for the treatment of bipolar disorder
|
Author keywords
Bipolar disorder; Lithium; Mania; Manic depressive illness; Mood stabilizer
|
Indexed keywords
ANTIDEPRESSANT AGENT;
BENZODIAZEPINE DERIVATIVE;
CARBAMAZEPINE;
CHLORPROMAZINE;
CLONAZEPAM;
DIAZEPAM;
DROPERIDOL;
HALOPERIDOL;
LAMOTRIGINE;
LITHIUM SALT;
LORAZEPAM;
MIDAZOLAM;
MIRTAZAPINE;
MONOAMINE OXIDASE INHIBITOR;
MOOD STABILIZER;
NEFAZODONE;
NEUROLEPTIC AGENT;
OLANZAPINE;
REBOXETINE;
RISPERIDONE;
SEROTONIN UPTAKE INHIBITOR;
THIORIDAZINE;
TRICYCLIC ANTIDEPRESSANT AGENT;
UNCLASSIFIED DRUG;
VALPROATE SEMISODIUM;
VALPROIC ACID;
VENLAFAXINE;
ZUCLOPENTHIXOL;
BIPOLAR DISORDER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CONVALESCENCE;
DEPRESSION;
DRUG APPROVAL;
DRUG BLOOD LEVEL;
DRUG CHOICE;
DRUG DOSE REGIMEN;
DRUG ERUPTION;
DRUG TOLERABILITY;
EVIDENCE BASED MEDICINE;
HUMAN;
LONG TERM CARE;
MANIA;
META ANALYSIS;
MIXED MANIA AND DEPRESSION;
MOOD DISORDER;
POPULATION RESEARCH;
PRACTICE GUIDELINE;
PREVALENCE;
PSYCHOLOGIC ASSESSMENT;
PSYCHOTHERAPY;
RANDOMIZED CONTROLLED TRIAL;
SHORT SURVEY;
SIDE EFFECT;
TREATMENT FAILURE;
|
EID: 0037541208
PISSN: 10398562
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1440-1665.2003.00520.x Document Type: Short Survey |
Times cited : (12)
|
References (4)
|